BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30738829)

  • 1. Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis.
    Wang X; He S; Gu Y; Wang Q; Chu X; Jin M; Xu L; Wu Q; Zhou Q; Wang B; Zhang Y; Wang H; Zheng L
    EBioMedicine; 2019 Feb; 40():251-262. PubMed ID: 30738829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of GPR120 promotes the metastasis of breast cancer through the PI3K/Akt/NF-κB signaling pathway.
    Zhang M; Qiu S
    Anticancer Drugs; 2019 Mar; 30(3):260-270. PubMed ID: 30520776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.
    Park S; Shimizu C; Shimoyama T; Takeda M; Ando M; Kohno T; Katsumata N; Kang YK; Nishio K; Fujiwara Y
    Breast Cancer Res Treat; 2006 Sep; 99(1):9-17. PubMed ID: 16752223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.
    Zhang W; Ding W; Chen Y; Feng M; Ouyang Y; Yu Y; He Z
    Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):647-53. PubMed ID: 21712253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
    Baxter DE; Kim B; Hanby AM; Verghese ET; Sims AH; Hughes TA
    Clin Breast Cancer; 2018 Dec; 18(6):481-488. PubMed ID: 30055962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of GPR120 in the maintenance of pregnancy by promoting decidualization via regulation of glucose metabolism.
    Huang J; Xue M; Zhang J; Yu H; Gu Y; Du M; Ye W; Wan B; Jin M; Zhang Y
    EBioMedicine; 2019 Jan; 39():540-551. PubMed ID: 30578080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma.
    Wu Q; Wang H; Zhao X; Shi Y; Jin M; Wan B; Xu H; Cheng Y; Ge H; Zhang Y
    Oncogene; 2013 Dec; 32(49):5541-50. PubMed ID: 23851494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.
    Naik A; Al-Yahyaee A; Abdullah N; Sam JE; Al-Zeheimi N; Yaish MW; Adham SA
    BMC Cancer; 2018 May; 18(1):533. PubMed ID: 29728077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
    Jiang L; Ren L; Zhang X; Chen H; Chen X; Lin C; Wang L; Hou N; Pan J; Zhou Z; Huang H; Huang D; Yang J; Liang Y; Li J
    EBioMedicine; 2019 May; 43():188-200. PubMed ID: 30979686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell density modulates chemoresistance in breast cancer cells through differential expression of ABC transporters.
    Shivhare S; Das A
    Mol Biol Rep; 2023 Jan; 50(1):215-225. PubMed ID: 36319789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
    De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
    Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
    Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
    Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway.
    Chen Q; Shen H; Zhu X; Liu Y; Yang H; Chen H; Xiong S; Chi H; Xu W
    Cancer Sci; 2020 Sep; 111(9):3279-3291. PubMed ID: 32619088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer.
    Chu X; Zhou Q; Xu Y; Jiang J; Li Q; Zhou Q; Wu Q; Jin M; Wang H; Gu Y; Wang X; Wang B; He S; He X; Wu C; Zhang F; Zhang Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):100. PubMed ID: 30795784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
    Adamska A; Falasca M
    World J Gastroenterol; 2018 Aug; 24(29):3222-3238. PubMed ID: 30090003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
    Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X
    Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
    Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.